| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/2003 | WO2003077874A2 Substituted tetrahydroisoquinoline compounds, methods of making, and their use |
| 09/25/2003 | WO2003077869A2 Neuroprotective spirostenol pharmaceutical compositions |
| 09/25/2003 | WO2003077867A2 Naltrexone hydrochloride compositions |
| 09/25/2003 | WO2003077863A2 Method for overexpression of zwitterionic polysaccharides |
| 09/25/2003 | WO2003077862A2 Potent, simplified derivatives of immunosuppressive agents |
| 09/25/2003 | WO2003077860A2 BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES |
| 09/25/2003 | WO2003077857A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 09/25/2003 | WO2003077855A2 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 09/25/2003 | WO2003077850A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 09/25/2003 | WO2003077847A2 Substituted amides |
| 09/25/2003 | WO2003077845A2 Compositions and methods for treating glaucoma and ocular hypertension |
| 09/25/2003 | WO2003077842A2 Palatable oral suspension and method |
| 09/25/2003 | WO2003077835A2 Sodium dodecyl sulfate compositions for inactivating prions |
| 09/25/2003 | WO2003077834A2 Central airway administration for systemic delivery of therapeutics |
| 09/25/2003 | WO2003077832A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 09/25/2003 | WO2003077831A2 Compositions and methods for treating mdma-induced toxicity |
| 09/25/2003 | WO2003077830A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 09/25/2003 | WO2003077828A2 Novel florfenicol-type antibiotics |
| 09/25/2003 | WO2003077723A2 Methods and devices for detection and therapy of atheromatous plaque |
| 09/25/2003 | WO2003077657A1 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 09/25/2003 | WO2003077656A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| 09/25/2003 | WO2003077653A1 Autoinducer compounds |
| 09/25/2003 | WO2003070738A3 Topiramate salts and compositions comprising and methods of making and using the same |
| 09/25/2003 | WO2003068171A3 Method and composition for treatment of inflammation and aids-associated neurological disorders |
| 09/25/2003 | WO2003068159A3 Compositions and methods for treating pain using cyclooxygenase-1 inhibitors |
| 09/25/2003 | WO2003061594A3 Methods and compositions for reducing the development of drug tolerance and/or physical dependence |
| 09/25/2003 | WO2003061568A3 Methods and therapeutic compositions in the treatment of advanced cancer |
| 09/25/2003 | WO2003059277A3 Methods and compositions for stimulating bone growth using inhibitors of microtubule assembly |
| 09/25/2003 | WO2003047552A3 Pharmaceutical composition comprising a 5ht1 receptor agonist |
| 09/25/2003 | WO2003045434A3 Endothelin antagonists ina method and composition for potentiating an opiate analgesic |
| 09/25/2003 | WO2003042411A3 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease |
| 09/25/2003 | WO2003041727A3 Plant derived or derivable material with appetite suppressing activity |
| 09/25/2003 | WO2003040368A3 Pharmaceutical compositions of marine sponge microciona prolifera |
| 09/25/2003 | WO2003039472A3 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 09/25/2003 | WO2003039451A3 Thiazole pyridazinones as adenosine antagonists |
| 09/25/2003 | WO2003037313A3 Methods for the treatment of addiction |
| 09/25/2003 | WO2003035059A3 Spermicides |
| 09/25/2003 | WO2003031643A9 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
| 09/25/2003 | WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof |
| 09/25/2003 | WO2003020219A3 Aerosolized decongestants for the treatment of sinusitis |
| 09/25/2003 | WO2003018064A3 Lipophilic drug compositions |
| 09/25/2003 | WO2003015690A3 Method for treating primary insomnia |
| 09/25/2003 | WO2003013537A3 Irinotecan for treatment of cancer |
| 09/25/2003 | WO2003013535A3 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 09/25/2003 | WO2003013530A3 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists |
| 09/25/2003 | WO2003011855A3 Pyrazole-derived kinase inhibitors and uses thereof |
| 09/25/2003 | WO2003011249A3 Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome |
| 09/25/2003 | WO2003008454A3 Glycoprotein vi fusion proteins |
| 09/25/2003 | WO2003007924A3 Combinations comprising epothilones and pharmaceutical uses thereof |
| 09/25/2003 | WO2003002114A3 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 09/25/2003 | WO2003002108A3 Use of tyrosine kinase inhibitors for treating inflammatory diseases |
| 09/25/2003 | WO2003001968A3 Compositions and methods for inhibiting platelet activation and thrombosis |
| 09/25/2003 | WO2003000709A3 Sialic acid derivatives for use as siglec inhibitors |
| 09/25/2003 | WO2002102981A3 SIR2α-BASED THERAPEUTIC AND PROPHYLACTIC METHODS |
| 09/25/2003 | WO2002102375A3 Imidazole derivatives for modulating sodium channels |
| 09/25/2003 | WO2002100827A9 Method for increasing the survival of dopamine secreting cells |
| 09/25/2003 | WO2002100818A3 Aminediols as agents for the treatment of alzheimer's disease |
| 09/25/2003 | WO2002100412A3 Stabilized dispersion of phytosterol in oil |
| 09/25/2003 | WO2002098339A3 Zinc containing compositions for anti-viral use |
| 09/25/2003 | WO2002097059A9 Chromosome-based platforms |
| 09/25/2003 | WO2002096357A3 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 09/25/2003 | WO2002094287A3 Identifying parasitic fungi of the organism, and treatment thereof |
| 09/25/2003 | WO2002094282A3 Compositions with methylprednisolone derivatives having therapeutic effect |
| 09/25/2003 | WO2002092826A3 Composition and method for treating cancer using herpes virus |
| 09/25/2003 | WO2002083112A3 Method for the treatment of polycystic kidney disease |
| 09/25/2003 | WO2002080911A3 Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments for the treatment of neurodegenerative diseases |
| 09/25/2003 | WO2002077263A3 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 09/25/2003 | WO2002076482A3 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS |
| 09/25/2003 | WO2002074733A3 Tryptase-inhibitors |
| 09/25/2003 | WO2002061128A3 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 09/25/2003 | WO2002060392A3 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 09/25/2003 | WO2002055688A8 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 09/25/2003 | WO2002046419A3 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 09/25/2003 | WO2002036573B1 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 09/25/2003 | WO2002032842A3 Compounds with high monoamine transporter affinity |
| 09/25/2003 | WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 09/25/2003 | WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 09/25/2003 | WO2002030448A3 Treatment of demyelinating diseases by administering gpe |
| 09/25/2003 | WO2002028432A3 Stem cell-based methods for preventing and treating tumor |
| 09/25/2003 | WO2002028355A3 Methods and compositions for enhancing angiogenesis |
| 09/25/2003 | WO2002024690A3 Efficient process for the preparation of a factor xa inhibitor |
| 09/25/2003 | WO2002022115A3 Methods and compositions for treating nail fungus |
| 09/25/2003 | WO2002017855A3 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 09/25/2003 | WO2002015922A3 New uses for amino acid anticonvulsants for treatment of pain |
| 09/25/2003 | WO2002013833A3 SMALL MOLECULE INHIBITORS TARGETED AT Bcl-2 |
| 09/25/2003 | WO2002013807A3 Compounds for the treatment of addictive disorders |
| 09/25/2003 | WO2002011670A3 Solid forms of tin ethyl etiopurpurin and processes for producing such forms |
| 09/25/2003 | WO2002010378A3 Antisense modulation of ptp1b expression |
| 09/25/2003 | WO2002004433A3 Melanin concentrating hormone receptor ligands |
| 09/25/2003 | WO2002000240A3 Compositions and methods for treating females sexual response |
| 09/25/2003 | WO2001093921A3 Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion |
| 09/25/2003 | US20030181847 For topical treatment of nail diseases (onychomycosis) after forming aperture in infected nail with laser beam; fungicides (terbinafine) |
| 09/25/2003 | US20030181766 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them |
| 09/25/2003 | US20030181765 Reacting an azide compound with an amine to form an intermediate, reducting the azide of the intermediate to form amine; amidation, reduction of azide, azidation, blocking hydroxy group, lactonization and deblocking |
| 09/25/2003 | US20030181764 Acylsulfonamide derivatives containing fluorosubstitutedphenylethynyl group having a hypoglycemic effect and free of the side effect |
| 09/25/2003 | US20030181749 Unreacted relatively low molecular weight cyclic siloxanes and oligomers are removed from relatively high molecular weight sililcon oil or fluid by performing a supercritical carbon dioxide extraction of silicone oil |
| 09/25/2003 | US20030181728 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/25/2003 | US20030181720 Chemical intermediate for making fungicides; debromination, hydroxylation, formation/c-c/ |
| 09/25/2003 | US20030181716 Novel azepane derivatives |
| 09/25/2003 | US20030181714 Oligosaccharide chain, which contianing a terminal NeuNAc alpha 6 linked to a linear or branched polylcatosamine type structure containing at least 3 lactosamine; a linear or branched structure with two lactosamine and one lactose |